Literature DB >> 4014858

Size aspects of metered-dose inhaler aerosols.

C S Kim, D Trujillo, M A Sackner.   

Abstract

The aerodynamic size distribution of several bronchodilator and corticosteroid metered-dose inhaler (MDI) aerosols was estimated in both dry and humid (90% RH) air environments with a six-stage cascade impactor. The distribution of aerosol size that penetrated into a simulated lung model were also measured. The size distributions were approximately log-normal and ranged from 2.4 to 5.5 micron in mass median aerodynamic diameter (MMAD) with geometric standard deviation (GSD) of 1.7 to 2.5 in a dry environment. In humid air, MMAD increased from 1 to 26% above the dry air state, but GSD remained unchanged. The size of aerosol delivered by MDI that penetrated into a simulated lung model fell to 2.4 to 2.8 micron in MMAD (GSD, 1.9 to 2.2). In contrast to aerosols produced by MDI, MMAD of an aerosol of cromolyn sodium powder dispersed by a Spinhaler increased rapidly with increasing humidity, 5.6 +/- 0.3 micron in dry air and 10.1 +/- 0.8 micron in 90% RH air. Finally, the factors influencing size of MDI-delivered aerosols, including formulation, canister pressure, physicochemical properties of propellants, and design of the valve and actuator orifices are discussed. Effective delivery of MDI-generated aerosols into the lung is highly dependent on particle dynamics and jet flow, and no single parameter can produce a unique particle size and jet pattern.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4014858     DOI: 10.1164/arrd.1985.132.1.137

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Optimized inhalation aerosols. II. Inertial testing methods for particle size analysis of pressurized inhalers.

Authors:  E M Phillips; P R Byron; K Fults; A J Hickey
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

2.  Effect of drug load and plate coating on the particle size distribution of a commercial albuterol metered dose inhaler (MDI) determined using the Andersen and Marple-Miller cascade impactors.

Authors:  M M Nasr; D L Ross; N C Miller
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

3.  Bioequivalence of generic aerosol bronchodilators: what are the issues?

Authors:  M Spino
Journal:  CMAJ       Date:  1989-11-01       Impact factor: 8.262

Review 4.  Behavior of hygroscopic pharmaceutical aerosols and the influence of hydrophobic additives.

Authors:  A J Hickey; T B Martonen
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

5.  Loading effect on particle size measurements by inertial sampling of albuterol metered dose inhalers.

Authors:  M M Nasr; J F Allgire
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

6.  Comparison of aerosol formulations of formoterol fumarate and budesonide.

Authors:  N M Nirale; M S Nagarsenker; S B Mendon; R Chanagare; A Katkurwar; V Lugade
Journal:  Indian J Pharm Sci       Date:  2011-05       Impact factor: 0.975

7.  Water Uptake by Evaporating pMDI Aerosol Prior to Inhalation Affects Both Regional and Total Deposition in the Respiratory System.

Authors:  Victoria Legh-Land; Allen E Haddrell; David Lewis; Darragh Murnane; Jonathan P Reid
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.